NCT03396250 - A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

March 26, 2018

Study Completion Date

March 29, 2018

Conditions

Pain

Interventions

DRUG

Naproxen sodium and diphenhydramine hydrochloride soft capsules

Single oral administration of Naproxen sodium 220 mg/DPH HCl 25mg (2 capsules)

DRUG

Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve, PMBAY98-7111)

Single administration of Naproxen sodium 220 mg/DPH HCl 25mg (2 tablets)

Trial Locations (1)

ICON Development Solutions, LLC, San Antonio